ghk-cu bpc 157 Glow (BPC-157/TB-500/GHK-Cu) — IVs in the Keys KLOW BLEND Peptide (80mg) |

5-Amino-1MQ is an orally bioavailable, cell-permeable small molecule that potently inhibits NNMT (nicotinamide N-methyltransferase), the enzyme responsible for methylating nicotinamide to 1-methylnicotinamide (1-MNA)

Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs

If it is not commonly available in your area, and you are a regular shopper at drug marts, you can ask them to source it for you

The Non-Negotiable Role of Peptide Purity Weve touched on this, but it deserves its own section

Swab the rubber septum with 70% isopropyl alcohol before each needle entry and allow to dry before insertion